Search Results
Sep 10, 2026, 19:20 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tyra Biosciences, Inc. ("Tyra" or the "Company") (NASDAQ: TYRA). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Sep 09, 2026, 09:15 ET Heartland Dental awards $34,500 in scholarships to students at Concorde Career Colleges campuses nationwide
include:Kaitlyn Faggiano, Concorde–DenverCalista Jamnik, Concorde–DenverBianca Purkett, Concorde–JacksonvilleTyra Carter, Concorde–JacksonvilleJenae McKinney, Concorde–MiramarFedlene Sainvil, Concorde–MiramarElizabeth Cagle, Concorde–OrlandoSavens
More news about: Concorde Career Colleges
Sep 09, 2026, 07:00 ET Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
Pediatric Disease Designation to oral dabogratinib for the treatment of achondroplasia.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Sep 08, 2026, 16:05 ET Tyra Biosciences to Present at the Cantor Global Healthcare Conference
website and will be available for replay following the event.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Sep 04, 2026, 08:00 ET Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
replay of the conference call and webcast will be archived on the Company's website for at least 90 days.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Aug 13, 2026, 09:00 ET Paddletek Named Official Paddle and Ball Partner of Chicken N Pickle
exhibitions, product demonstrations and community events.Paddletek's professional roster includes Christian Alshon, JW Johnson, Jorja Johnson, Tyra Black, Zane Navratil, Riley Newman, Connor Garnett and other established and rising players. Participating athletes, event locations and registration
More news about: Paddletek Group
Aug 04, 2026, 16:05 ET Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
Patients page of our website for more information on our clinical trials.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Jul 29, 2026, 18:41 ET Mockett Introduces the HK40 Hook, an Architectural Wall Accessory
biggest statement."The Mockett Design Competition has always been about discovering fresh ideas and helping new designers bring them to life," said Tyra Cunningham, President of Mockett. "The HK40 is a perfect example of that mission. What began as a creative concept from a talented designer has become
More news about: Doug Mockett & Company
Jul 21, 2026, 10:20 ET Franchise FastLane Names Veteran Franchise Leader Heather Harris as Chief Executive Officer
brands."Heather is an accomplished executive with a proven track record of building high-performing organizations and helping franchise brands scale," said Vince Tyra, Partner at Southfield Capital. "Her operational expertise, strategic mindset, and people-first leadership style qualifies her to lead Franchise FastLane
More news about: Southfield Capital
Jul 21, 2026, 01:57 ET Vår Energi to combine with BlueNord, building the largest independent producer of oil and gas in Europe
supply of energy to Europe and meaningful returns to shareholders. Since 2019, our shareholders have supported BlueNord through the delivery of the Tyra Redevelopment and benefited from a period of outsized distributions of close to USD 800 million. This transaction is the natural next phase: it gives
More news about: BlueNord ASA
Jul 09, 2026, 02:00 ET BlueNord Announces Second Quarter and First Half 2026 Results and Declares Cash Dividend for the Quarter
reflecting the planned maintenance shutdowns at both the Tyra and Gorm hubs during the quarter. The Tyra hub produced 19.3 mboepd, with the planned June shutdown successfully completed and the full work scope executed. Following the restart, Tyra exited the quarter producing at record gas rates above 250
More news about: BlueNord ASA
Jul 08, 2026, 09:00 ET Akeneo Introduces the First Truly Agentic Product Experience Platform
pace with new patterns of discovery, more channels, and faster generational cycles, product data needs to be more dynamic and responsive," said Andy Tyra, Chief Product Officer at Akeneo. "The organizations that succeed will be those that can continuously improve product experiences instead of periodically
More news about: Akeneo
Jul 07, 2026, 07:30 ET Paddletek Group Announces Landmark Move: Acquisition of PIKKL and signing of JW, Jorja, Julie Johnson and Hurricane Tyra Black
Martinson. The company has also expanded Team Paddletek with the signing of professional stars JW Johnson, Jorja Johnson, Julie Johnson and Hurricane Tyra Black. Prior to the acquisition, Paddletek had been closely evaluating PIKKL and its unique approach to performance innovation as part of a strategy
More news about: Paddletek Group
Jun 23, 2026, 10:31 ET Non-muscle Invasive Bladder Cancer Market Dynamics to Shift During the Forecast Period (2026-2036) as Novel Targeted and Gene Therapies Enter Late-Stage Development | DelveInsight
therapies such as CG0070 (cretostimogene grenadenorepvec) (CG Oncology), EG-70 (detalimogene voraplasmid) (enGene), TAR-210 (Janssen), Dabogratinib (Tyra Biosciences), UGN-103 (UroGen Pharma), TARA-002 (Protara Therapeutics), and others.LAS VEGAS,
More news about: DelveInsight Business Research, LLP
Jun 11, 2026, 10:00 ET PLEX AND ATX TV ANNOUNCE FRIDAY NIGHT LIGHTS ROADSHOW TO CELEBRATE SERIES' 20TH ANNIVERSARY
for Friday Night Lights' fans ahead of the official 20th anniversary of its premiere. At each tour stop this summer, Adrianne Palicki ("Tyra Collette") will be joined by different cast members, who will introduce a screening of their favorite episode from the series before taking part in
More news about: Plex, Inc.
May 21, 2026, 08:00 ET TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY
today – and champions innovative research and responsive national policy to inspire hope for tomorrow.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
May 13, 2026, 08:00 ET Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
Patients page of our website for more information on our clinical trials.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
May 07, 2026, 16:05 ET Tyra Biosciences to Participate in Upcoming Investor Conferences
website and will be available for replay following the event.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
May 04, 2026, 01:21 ET BlueNord Announces First Quarter 2026 Results and Proposed Cash Dividend for the Quarter
range of 42.0-45.0 mboepd. The performance reflects continued improvement at the Tyra hub with its highest quarterly contribution of 22.9 mboepd since restart, alongside stable contribution from the base assets. At Tyra the successful execution of the walk-to-work campaign took place in March, resulting
More news about: BlueNord ASA
Apr 30, 2026, 23:35 ET GIL Shareholder Alert: Gildan Activewear Inc. Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
every category... we are outperforming the market." On December 11, 2023, the Gildan board announced it had terminated Chamandy and appointed Vince Tyra to be president and CEO. GIL shares immediately fell 10% in a single session.After a lengthy and high-profile proxy battle in which Gildan spent
More news about: Levi & Korsinsky, LLP
Apr 21, 2026, 10:00 ET Akeneo Architects "The Great Restack" of Global Commerce with Adaptive Product Cloud Evolution
where AI-powered discovery will be the new standard, product data is the foundation more than ever and must be resilient and market-aware," said Andy Tyra, Akeneo Chief Product Officer. "We are bridging the gap between market signals and PIM architecture to provide the resilient foundation required for
More news about: Akeneo
Apr 17, 2026, 08:00 ET Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
grateful for her leadership and support during the early phase of our growth," added Bob More, Chairman of TYRA.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that
More news about: Tyra Biosciences
Apr 02, 2026, 08:30 ET APUS Recognizes Academic Excellence with First Quarter 2026 President's List
Amy TiongcoTyra Bergan
More news about: American Public University System
Mar 25, 2026, 08:57 ET Children's Hospital of Philadelphia Researchers Uncover "Leaky Pipeline" of Escalating Disparities Across the Care Pathway for Pediatric Head Injury Patients
Tyra Bryant-Stephens, MD, CHOP Associate Vice President and Chief Health Equity Officer. "We can apply our findings from this study of concussion to
More news about: Children's Hospital of Philadelphia
Mar 02, 2026, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
Patients page of our website for more information on our clinical trials.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences